Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
Phase 2
36
about 4.5 years
18+
1 site in OH
What this study is about
Researchers are testing if adding the specific combination of donors can result in acceptable levels of survival without evidence of disease. The trial is testing a treatment that involves transplanting cord blood and haplo-identical grafts together.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Haplo-Identical / Cord Blood Transplant
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Progression free survival(PFS) at 6 months after transplant
Secondary: Graft versus host disease relapse free survival at 1 year after transplant, Graft versus host disease relapse free survival at 2 years after transplant, Graft versus host disease relapse free survival at 3 years after transplant, Overall survival at 2 years after transplant, Overall survival at 3 years after transplant, Overall survival(OS) at 1 year after transplant, Progression free survival at 1 year after transplant, Progression free survival at 2 years after transplant
Oncology